Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 2,366 shares at $102.68 ($246K) on 2024-11-07, disclosed to the SEC on 2024-11-08.
Scheduled sale ($246k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.64 | 281 | $29K | 11.7% |
| 2 | $102.68 | 227 | $23K | 9.5% |
| 3 | $103.36 | 363 | $38K | 15.3% |
| 4 | $103.43 | 463 | $48K | 19.5% |
| 5 | $104.71 | 377 | $39K | 16.1% |
| 6 | $104.72 | 434 |
| $45K |
| 18.5% |
| 7 | $105.50 | 116 | $12K | 5.0% |
| 8 | $105.50 | 105 | $11K | 4.5% |
| Total | $103.89 avg | 2,366 | $246K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |